OKYO Pharma Limited Increase Decrease Through Exercise Of Warrants Equity
OKYO Pharma Limited (OKYO) reported Increase Decrease Through Exercise Of Warrants Equity of $1.46 million for the 12-month period ending 2022-03-31, per its 20-F filed 2024-08-13.
Discontinued › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2024-08-13
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|
| 2022-03-31 | $1.46M 20-F · filed 2024-08-13 |